Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DNLI – Denali Therapeutics Inc.

Denali Therapeutics Inc.
DNLI
$17.98
Name : Denali Therapeutics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $2,807,727,360.00
EPSttm : -2.92
finviz dynamic chart for DNLI
Denali Therapeutics Inc.
$17.98
3.51%
$0.61

Float Short %

9.95

Margin Of Safety %

Put/Call OI Ratio

0.67

EPS Next Q Diff

-0.03

EPS Last/This Y

-0.44

EPS This/Next Y

0.04

Price

17.99

Target Price

32.21

Analyst Recom

1.06

Performance Q

36.63

Relative Volume

0.75

Beta

1.04

Ticker: DNLI



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13DNLI17.150.760.002392
2025-11-14DNLI17.440.760.062392
2025-11-17DNLI17.370.750.002414
2025-11-18DNLI17.470.750.162415
2025-11-19DNLI16.920.75999.992436
2025-11-20DNLI17.170.750.022435
2025-11-21DNLI17.990.730.102466
2025-11-24DNLI18.960.370.071729
2025-11-25DNLI19.140.350.011783
2025-11-26DNLI19.410.330.031873
2025-12-01DNLI18.170.3317.271870
2025-12-02DNLI17.840.510.292138
2025-12-03DNLI18.990.510.272146
2025-12-04DNLI20.110.510.062173
2025-12-05DNLI19.960.510.002147
2025-12-08DNLI19.680.510.032153
2025-12-09DNLI18.970.480.772257
2025-12-10DNLI17.550.485.872265
2025-12-11DNLI17.350.700.062637
2025-12-12DNLI180.670.002720
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-13DNLI17.14-18.6224.8-3.04
2025-11-14DNLI17.44-18.6206.0-3.04
2025-11-17DNLI17.36-17.3216.4-3.02
2025-11-18DNLI17.47-15.4211.6-3.00
2025-11-19DNLI16.92-15.4229.9-3.00
2025-11-20DNLI17.17-13.9207.0-2.99
2025-11-21DNLI17.98-14.1190.9-2.99
2025-11-24DNLI18.96-14.1188.5-2.99
2025-11-25DNLI19.13-14.1210.1-2.99
2025-11-26DNLI19.42-14.1207.4-2.99
2025-12-01DNLI18.16-14.1245.5-2.99
2025-12-02DNLI17.84-14.1223.0-2.99
2025-12-03DNLI19.00-14.1183.3-2.99
2025-12-04DNLI20.11-14.1186.9-2.99
2025-12-05DNLI19.96-14.1217.7-2.99
2025-12-08DNLI19.69-14.1- -3.01
2025-12-09DNLI19.66-14.1215.2-3.01
2025-12-10DNLI17.55-14.1264.0-3.01
2025-12-11DNLI17.36-14.1220.0-3.01
2025-12-12DNLI17.99-14.1197.4-3.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13DNLI-3.143.569.99
2025-11-14DNLI-3.143.569.98
2025-11-17DNLI-3.195.509.98
2025-11-18DNLI-3.195.509.98
2025-11-19DNLI-3.195.509.98
2025-11-20DNLI-3.195.509.98
2025-11-21DNLI-3.195.5010.05
2025-11-24DNLI-3.001.7310.05
2025-11-25DNLI-3.001.7310.05
2025-11-26DNLI-3.001.7310.74
2025-12-01DNLI-3.001.7310.74
2025-12-02DNLI-3.001.7310.74
2025-12-03DNLI-3.001.7310.74
2025-12-04DNLI-3.001.7310.74
2025-12-05DNLI-3.001.7310.74
2025-12-08DNLI-3.001.7510.74
2025-12-09DNLI-3.001.7510.74
2025-12-10DNLI-3.001.759.95
2025-12-11DNLI-3.001.759.95
2025-12-12DNLI-3.001.759.95
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="DNLI" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS​

-0.74

Avg. EPS Est. Current Quarter

-0.76

Avg. EPS Est. Next Quarter

-0.77

Insider Transactions

-3

Institutional Transactions

1.75

Beta

1.04

Average Sales Estimate Current Quarter

2

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

6

Growth Score

22

Sentiment Score

3

Actual DrawDown %

80.9

Max Drawdown 5-Year %

-87.7

Target Price

32.21

P/E

Forward P/E

PEG

P/S

P/B

2.85

P/Free Cash Flow

EPS

-2.91

Average EPS Est. Cur. Y​

-3.01

EPS Next Y. (Est.)

-2.97

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.75

Return on Equity vs Sector %

-80.8

Return on Equity vs Industry %

-65.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

197.4
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”DNLI” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNLI” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNLI” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNLI” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNLI” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNLI” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNLI” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Denali Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 517
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; DNL343 eIF2B activator program for amyotrophic lateral sclerosis; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
stock quote shares DNLI – Denali Therapeutics Inc. Stock Price stock today
news today DNLI – Denali Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DNLI – Denali Therapeutics Inc. yahoo finance google finance
stock history DNLI – Denali Therapeutics Inc. invest stock market
stock prices DNLI premarket after hours
ticker DNLI fair value insiders trading